School of Medicine
Showing 21-40 of 47 Results
Instructor, Pediatrics - Cardiology
BioDr. Martin R. Pfaller is an Instructor in the Department of Pediatrics (Cardiology) in the group of Alison L. Marsden. He received his B.Sc., M.Sc., and Ph.D. in Mechanical Engineering from the Technical University of Munich, working with Wolfgang A. Wall. During his Ph.D., he validated an efficient yet physiologically accurate boundary condition to account for the mechanical support of the heart within its surroundings, which has been adopted by various research groups worldwide. He further demonstrated how projection-based model order reduction could speed up model personalization from patient data, such as magnetic resonance imaging or blood pressure measurements. His current work focuses on cardiovascular fluid dynamics. He developed reduced-physics models to make blood flow simulations faster and more reliable. Further, he implemented a fluid-solid-growth interaction model in blood vessels in collaboration with Jay D. Humphrey at Yale University. His future research will predict the heart’s long-term function in heart diseases, supported by an NIH Pathway to Independence Award (K99/R00). He will quantify the risk of heart failure after a heart attack with a stability analysis validated with imaging data in swine and humans. This research will improve our understanding of biomechanical mechanisms leading to heart failure and help to identify patients at risk, enable personalized therapies, and facilitate the optimal design of medical devices.
Professor of Pediatrics at the El Camino Hospital, Emeritus
Current Research and Scholarly InterestsNeonatal infection: Primarily the evaluation of diagnostic tests and how they may be incorporated into decisions concerning duration of antibiotic therapy. Also interested in the epidemiology and management of sepsis and meningitis.
Intraventricular hemorrhage: Involved in a multicenter randomized controlled trial of prophylactic indomethacin administration. Also involved with studies relating to the etiology of this disorder in newborn infants.
Professor of Pathology, of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases)
Current Research and Scholarly InterestsDevelopment and application of molecular assays for the diagnosis and management of infectious diseases.
Maryann Abiodun Pitts, MD
Clinical Instructor, Pediatrics - General Pediatrics
BioDr. Pitts is a board-certified pediatrician. She has served as a clinical instructor and assistant clinical professor (affiliated) in the Department of Pediatrics at Stanford University School of Medicine.
She provides care to children and adolescents. Among the services she delivers are well check-ups, vaccinations, acute care, mental health support, and preventive care.
When patients meet with Dr. Pitts, it is important to her that they always feel respected and heard. If they are not ready or able to answer a question, or if they feel more at ease with a different approach to their appointment, she will always honor how they are feeling.
Dr. Pitts also works with the community to strengthen the systems that support healthy children and families. She has extensive experience collaborating with community-based organizations and government agencies. Her experience includes serving as a physician partner to the Adverse Childhood Experiences (ACEs) Aware Initiative. This program develops methods to screen patients and create treatment plans designed to help them heal from the impacts of trauma and toxic stress.
Her leadership experience includes co-founding POWER: Pediatricians Organizing and Working to End Racism and developing diversity, equity, and inclusion initiatives within health institutions. As an invited speaker at regional and national events, she has made many presentations to her peers. She also served as a health equity panelist for the National Academies of Sciences, Engineering and Medicine.
Dr. Pitts speaks both English and Spanish.
Clinical Professor, Pediatrics
Clinical Professor, Emergency Medicine
Clinical Professor, Emergency Medicine
Current Research and Scholarly InterestsDr. Platchek's research interest focuses on improving value in healthcare delivery using healthcare model design thinking and a "Lean" business strategy. Dr. Platchek is also interested in effective methods for engaging clinicians in systems-based clinical improvement efforts.
Sutardja Chuk Professor of Definitive and Curative Medicine
BioDr. Porteus was raised in California and was a local graduate of Gunn High School before completing A.B. degree in “History and Science” at Harvard University where he graduated Magna Cum Laude and wrote an thesis entitled “Safe or Dangerous Chimeras: The recombinant DNA controversy as a conflict between differing socially constructed interpretations of recombinant DNA technology.” He then returned to the area and completed his combined MD, PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development with his PhD thesis entitled “Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development.” After completion of his dual degree program, he was an intern and resident in Pediatrics at Boston Children’s Hospital and then completed his Pediatric Hematology/Oncology fellowship in the combined Boston Chidlren’s Hospital/Dana Farber Cancer Institute program. For his fellowship and post-doctoral research he worked with Dr. David Baltimore at MIT and CalTech where he began his studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Following his training with Dr. Baltimore, he took an independent faculty position at UT Southwestern in the Departments of Pediatrics and Biochemistry before again returning to Stanford in 2010 as an Associate Professor. During this time his work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and is considered one of the pioneers and founders of the field of genome editing—a field that now encompasses thousands of labs and several new companies throughout the world. His research program continues to focus on developing genome editing by homologous recombination as curative therapy for children with genetic diseases but also has interests in the clonal dynamics of heterogeneous populations and the use of genome editing to better understand diseases that affect children including infant leukemias and genetic diseases that affect the muscle. Clinically, Dr. Porteus attends at the Lucille Packard Children’s Hospital where he takes care of pediatric patients undergoing hematopoietic stem cell transplantation.
Clinical Assistant Professor, Pediatrics - Hematology & Oncology
Current Research and Scholarly InterestsSolid Tumors, Bone Sarcomas, Global Oncology, Health Disparities
Adjunct Clinical Assistant Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsThe Priest lab seeks a better understanding of the genetics and pathogenesis of congenital heart disease using translational genomics, big-data, and vertebrate models of cardiac development.
Philip Sunshine, MD, Professor of Neonatology
BioLawrence (Lance) S. Prince, MD, PhD, is the Division Chief for Neonatal and Developmental Medicine at Stanford School of Medicine. Dr. Prince was previously a Professor of Pediatrics and Chief of the Division of Neonatology at the University of California, San Diego and Rady Children’s Hospital, San Diego.
Dr. Prince has a long and distinguished career mentoring clinical and scientific trainees and students, many of whom have gone on to establish their own successful careers as academic physician investigators. As a physician scientist, Dr. Prince leads a basic science laboratory focusing on the mechanisms regulating developmental immunology and lung injury and repair. Dr. Prince received a Bachelor of Science in Chemistry from University of Miami, an MD/PhD with a focus in Cell Biology from University of Alabama at Birmingham, and postdoctoral fellowship, Pediatrics residency, and Neonatal-Perinatal Medicine Fellowship training at the University of Iowa. Before arriving in California, Dr. Prince was an Associate Professor of Pediatrics at Vanderbilt University.
Dr. Prince’s research interests include the molecular and cellular mechanisms controlling lung development and the maturation of the fetal and neonatal immune systems. He has a particular clinical interest in managing and treating neonatal lung diseases, especially bronchopulmonary dysplasia (BPD) in babies born extremely preterm. Dr. Prince’s research team focuses primarily on the development of innate immunity during fetal life as it impacts health and disease in preterm infants. The laboratory is investigating how microbes including Group B streptococcus exploit the unique features of neonatal macrophages to avoid immune detection and cause disease, as well as leading a number of clinical and translational investigations.
Charles G. Prober, MD
Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsMy research interest is in the epidemiology, pathophysiology, prevention, and treatment of infections in children. Much of this research has focused on viral infections, especially those caused by herpes simplex virus (HSV). I have conducted a number of studies concerned with the epidemiology of HSV-2 infections in pregnant women, their partners, and neonates.
Professor of Pediatrics (Neonatology)
Current Research and Scholarly InterestsFunded by NIH R01 grants:
1) Development and application of composite measure of NICU quality - Baby-MONITOR
2) High reliability, safety culture and caregiver resilience as modifiers of care quality
3) Modifiable racial/ethnic disparities in quality of care delivery
4) Effectiveness of regionalized care delivery systems for preterm newborns